These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 6705899)

  • 21. Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation.
    Singh G; Renton KW
    Mol Pharmacol; 1981 Nov; 20(3):681-4. PubMed ID: 6173738
    [No Abstract]   [Full Text] [Related]  

  • 22. [The sequelae of cytochrome P-450 induction].
    Lukienko PI; Zavodnik LB; Bushma MI
    Eksp Klin Farmakol; 1995; 58(1):68-73. PubMed ID: 7787705
    [No Abstract]   [Full Text] [Related]  

  • 23. Species differences in phenytoin induction of cytochrome P450 due to pharmacokinetic differences.
    Billings RE; Hansen DK
    Proc West Pharmacol Soc; 1984; 27():539-42. PubMed ID: 6494195
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro studies of induction and inhibition of drug oxidation in man.
    Boobis AR; Murray S; Seddon CE; Davies DS
    Pharmacol Ther; 1987; 33(1):101-8. PubMed ID: 3628467
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of the microsomal enzymatic activity changes induced by peloid applications in the biotransformation and effect of pharmacological preparations].
    Leshchinskiĭ AF; Zolotareva TA; Golovenko Nia ; Stepanova EI
    Farmakol Toksikol; 1980; 43(6):705-8. PubMed ID: 7450009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 1980 Bernard B. Brodie award lecture. Drug metabolism by cytochrome P-450: progress and perspectives.
    Coon MJ
    Drug Metab Dispos; 1981; 9(1):1-4. PubMed ID: 6111423
    [No Abstract]   [Full Text] [Related]  

  • 28. [Liver and drug metabolism].
    Mikheeva OM
    Eksp Klin Gastroenterol; 2011; (2):121-4. PubMed ID: 21560652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of the inhibition of cytochrome P-450-mediated drug oxidation by therapeutic agents.
    Murray M
    Drug Metab Rev; 1987; 18(1):55-81. PubMed ID: 3311684
    [No Abstract]   [Full Text] [Related]  

  • 30. [Environmental effect on metabolism of exogenous molecules in liver microsomes].
    Albrecht R; Manchon P
    Ann Nutr Aliment; 1974; 28(4):351-63. PubMed ID: 4157001
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of cytochrome P-450 isoenzymes in the bioactivation of hydroxy anthraquinones.
    Fratta D; Simi S; Rainaldi G; Gervasi PG
    Anticancer Res; 1994; 14(6B):2597-603. PubMed ID: 7872687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract]   [Full Text] [Related]  

  • 34. [Description of cytochrome p-450 research].
    Wang XL
    Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):233-7. PubMed ID: 6359412
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of epoxy derivatives of benzo(a)pyrene by microsomal cytochrome P-450.
    Sugiura M; Yamazoe Y; Kamataki ; Kato R
    Cancer Res; 1980 Aug; 40(8 Pt 1):2910-4. PubMed ID: 6771009
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of bucid on oxidation-reduction processes in the microsomes and mitochondria of the animal liver].
    Sinitskaia TA; Kandul SV
    Gig Sanit; 1989 May; (5):87-8. PubMed ID: 2767469
    [No Abstract]   [Full Text] [Related]  

  • 37. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
    Carlile DJ; Hakooz N; Houston JB
    Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [P-450 cytochrome. Detoxication by liver microsomes].
    Gajdos A
    Nouv Presse Med; 1972 Jun; 1(23):1587-92. PubMed ID: 4402521
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent developments in toxicology.
    Parke DV
    Rocz Panstw Zakl Hig; 1985; 36(2):92-108. PubMed ID: 4048784
    [No Abstract]   [Full Text] [Related]  

  • 40. [Circadian rhythms in metabolism and susceptibility of drugs (author's transl)].
    Kato R; Muraki T
    Tanpakushitsu Kakusan Koso; 1982 Jan; 27(2):158-69. PubMed ID: 7041179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.